⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cilengitide

Every month we try and update this database with for cilengitide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaNCT00006222
Sarcoma
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide Imaging Trial in GlioblastomaNCT01558687
Supratentorial ...
Drug (including...
Standard therap...
18 Years - 70 YearsMerck KGaA, Darmstadt, Germany
Cilengitide in Treating Patients With Unresectable or Metastatic MelanomaNCT00082875
Stage III Melan...
Stage IV Melano...
cilengitide
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
EMD 121974 in Treating Patients With Progressive or Recurrent GliomaNCT00006093
Brain and Centr...
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter StatusNCT00689221
Glioblastoma
Cilengitide
Temozolomide
Radiotherapy
18 Years - EMD Serono
Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter GeneNCT01124240
Newly Diagnosed...
Cilengitide
18 Years - Northern Sydney and Central Coast Area Health Service
Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter GeneNCT01124240
Newly Diagnosed...
Cilengitide
18 Years - Northern Sydney and Central Coast Area Health Service
Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung CancerNCT00884598
Brain and Centr...
Lung Cancer
cilengitide
pharmacological...
radiation thera...
18 Years - Universitätsmedizin Mannheim
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsNCT01517776
Gliomas
Cilengitide
Temozolomide
3 Years - 17 YearsMartin-Luther-Universität Halle-Wittenberg
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter StatusNCT00813943
Glioblastoma
Cilengitide (2-...
cilengitide (5-...
Temozolomide
Radiotherapy
18 Years - EMD Serono
Cilengitide in Treating Patients With Acute Myeloid LeukemiaNCT00089388
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
cilengitide
50 Years - National Cancer Institute (NCI)
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00085254
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
cilengitide
temozolomide
radiation thera...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00085254
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
cilengitide
temozolomide
radiation thera...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
EMD 121974 in Treating Patients With Advanced Solid TumorsNCT00022113
Unspecified Adu...
cilengitide
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cilengitide in Treating Patients With Prostate CancerNCT00121238
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide in Treating Patients With Prostate CancerNCT00121238
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide in Treating Patients With Unresectable or Metastatic MelanomaNCT00082875
Stage III Melan...
Stage IV Melano...
cilengitide
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaNCT00979862
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
Cediranib Malea...
Cilengitide
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Cilengitide in Treating Patients With Metastatic Prostate CancerNCT00103337
Recurrent Prost...
Stage IV Prosta...
cilengitide
laboratory biom...
18 Years - National Cancer Institute (NCI)
EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaNCT00006222
Sarcoma
cilengitide
18 Years - National Cancer Institute (NCI)
EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaNCT00006222
Sarcoma
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)NCT00842712
Carcinoma, Non-...
Cilengitide
Cilengitide
Cetuximab
Cisplatin
Cisplatin
Gemcitabine
Vinorelbine
Cilengitide
Cilengitide
Cetuximab
Chemotherapy
18 Years - Merck KGaA, Darmstadt, Germany
Cilengitide in Treating Children With Refractory Primary Brain TumorsNCT00063973
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter GeneNCT01124240
Newly Diagnosed...
Cilengitide
18 Years - Northern Sydney and Central Coast Area Health Service
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNCT00679354
Childhood High-...
Childhood High-...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
pharmacological...
- 21 YearsNational Cancer Institute (NCI)
Cilengitide Imaging Trial in GlioblastomaNCT01558687
Supratentorial ...
Drug (including...
Standard therap...
18 Years - 70 YearsMerck KGaA, Darmstadt, Germany
Cilengitide in Treating Patients With Prostate CancerNCT00121238
Recurrent Prost...
Stage I Prostat...
Stage IIA Prost...
Stage IIB Prost...
Stage III Prost...
cilengitide
18 Years - National Cancer Institute (NCI)
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma MultiformeNCT00112866
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
cilengitide
therapeutic con...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)NCT01782976
Glioblastoma
Cilengitide
Bevacizumab
Questionnaire
18 Years - M.D. Anderson Cancer Center
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNCT00679354
Childhood High-...
Childhood High-...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
pharmacological...
- 21 YearsNational Cancer Institute (NCI)
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeNCT01122888
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Solid Neo...
Recurrent Adult...
Cilengitide
Clinical Observ...
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaNCT00979862
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
Cediranib Malea...
Cilengitide
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: